Doctors brace for questions with return of Johnson & Johnson vaccine

It would be “very reasonable” for some patients to opt for Moderna or Pfizer, but that doesn’t mean a woman under 50 would be wrong to select J&J, said Dr. Caitlin Eccles-Radtke, an infectious disease specialist at Hennepin Healthcare. The health system has found the one-shot vaccine helps immunize patients who can’t easily get to the clinic for two shots, so a patient’s access to health care can factor into the choice.

“Transparency and education are really critical in … letting people make a decision they feel comfortable with,” she said.